Mark Painter

Mark Painter

markmpainter.bsky.social

Postdoc immunologist with John Wherry at Penn, studying human T cell differentiation and immune responses to SARS-CoV-2, viral infections, Long COVID, and beyond

👤 Joined on 18 November 2024

173

Followers

143

Following

26

Total Posts

📜 Kullanıcı Geçmişi

  • 18 Kas 2024, 18:23
    🎉 Bluesky'e katıldı - İlk kullanıcı adı: @markmpainter.bsky.social

🚫 Blokladığı Kullanıcılar

❤️ Beğendiği Gönderiler

University of Pennsylvania researchers studied over 300 people and found 40% of Long COVID samples had elevated SARS-CoV-2-specific CD8 T cell activation, with signs of exhaustion and reduced function. This supports persistent viral antigen stimulation. www.biorxiv.org/content/10.6...

Show Post

@biorxivpreprint.bsky.social Persistently activated virus-specific CD8 T cells indicate antigen-driven immune aberrations in long COVID www.biorxiv.org/content/10.6... @ejohnwherry.bsky.social @upenn.edu @markmpainter.bsky.social

Show Post

I’m tired of the AI-generated pictures on slides 🥀🥀🥀 Especially slides w/ unclear graphs!! I’m telling you the image you have of an anime-looking group of scientists working together is way less useful than putting together some R-code to make sure you are clearly displaying your findings.

Show Post

Before talking about “non‑specific effects” of vaccines, it helps to revisit a basic point that easily gets lost: vaccines are not designed to boost the immune system in general. They work by selecting cells (B and T) that recognise very specific molecular features, antigens, of a specific pathogen.

Show Post

👩‍🔬 Viral Vax Lab is looking for a post-doc! We have a junior postdoctoral position available for someone who is excited about CD4 T cells, B cells, and vaccines against infectious disease. Come join us at UniMelb and the Doherty Institute! unimelb.wd105.myworkdayjobs.com/en-GB/UoM_Ex...

Show Post

Select language

Install App

Install App